Diabetes Care 24 (6), 10691078
Unbalanced levels of adrenal hormones can increase the generation of ROS, which increases the risk of oxidative damage
doi: 10.1093/humrep/deaa363 39
Read the FDAs full warning here: #GLP1 #ClinicalTrials #PatientSafety #AccessEquity #ObesityResearch #DecentralizedTrials FDA warns about unapproved GLP-1 drugs online, calls for accessible trials The FDA has issued warnings about unapproved GLP-1 drugs circulating online - counterfeit, compounded, or mislabeled as research use only. When access to legitimate GLP-1 clinical trials is limited - by geography, logistics, or site capacity - progress slows
With multiple locations across South Florida, plus mobile service to your home, office or hotel, better health is more accessible than ever
Some people may see considerable weight loss within the first week of treatment, while others may only see modest results